Pruritus Therapeutics Market To Reach $11.34 Billion By 2030

February 2025 | Report Format: Electronic (PDF)

Pruritus Therapeutics Market Growth & Trends

The global Pruritus Therapeutics market size is expected to reach USD 11.34 billion by 2030, registering a CAGR of 4.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. Growing worldwide prevalence of atopic dermatitis, allergic contact dermatitis, and urticaria is expected to drive market growth during the forecast period. The introduction of new products based on scientific mechanistic understanding such as the identification of new T-cell subsets, particularly Th17, and Th22 and the patent expiration of PROTOPIC (tacrolimus) is expected to open up new avenues for manufacturers to capitalize on over the forecast period. 

Corticosteroids were the leading product segment in 2013 owing to high efficacy exhibited by this class of drugs in treating pruritic conditions by reducing inflammation and itching. Topical applications of corticosteroids have been found to be extremely effective in the treatment and maintenance therapies pertaining to pruritus.


key Request a free sample copy or view report summary: Pruritus Therapeutics Market Report


Pruritus Therapeutics Market Report Highlights

  • Corticosteroids dominated the market and accounted for a share of 28.1% in 2024. Antihistamines are expected to register significant growth over the forecast period.

  • Hospital pharmacies dominated the market and accounted for a share of 49.8% in 2024. Online pharmacies are projected to grow at the fastest CAGR of 5.9% over the forecast period.

  • North America pruritus therapeutics market dominated the global market with a revenue share of 38.7% in 2024. The pruritus therapeutics market in the U.S. dominated the North America pruritus therapeutics market with a revenue share of 90.1% in 2024.

  • Asia Pacific pruritus therapeutics market is expected to register the fastest CAGR of 6.1% in the forecast period.India pruritus therapeutics market is expected to grow at the fastest rate over the forecast period in the Asia Pacific market.

Pruritus Therapeutics Market Segmentation

Grand View Research has segmented global pruritus therapeutics market report based on disease, product, distribution channel, and region:

Pruritus Therapeutics Disease Outlook (Revenue, USD Million, 2018 - 2030)

  • Atopic Dermatitis

  • Allergic Contact Dermatitis

  • Urticaria

  • Others

Pruritus Therapeutics Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Corticosteroids

  • Antihistamines

  • Local Anesthetics

  • Counterirritants

  • Immunosuppressant

  • Calcineurin Inhibitors

  • Others

Pruritus Therapeutics Distribution Chanel Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospital Pharmacies

  • Retail Pharmacies

  • Online Pharmacies 

Pruritus Therapeutics Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait

List of Key Players of Pruritus Therapeutics Market

  • AbbVie Inc.

  • Amgen, Inc.

  • Astellas Pharma Inc.

  • Bristol-Myers Squibb

  • Cara Therapeutics

  • GSK plc

  • Novartis AG

  • Pfizer Inc.

  • Sanofi

  • Teva Pharmaceutical Industries Ltd

gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn

NEED A CUSTOM REPORT?

We offer custom report options, including stand-alone sections and country-level data. Special pricing is available for start-ups and universities.

Request Customization